Brain cells that help make us human are also uniquely vulnerable to multiple sclerosis. A newfound cellular repair kit can’t keep up with the disease’s damage, leading to the cell death that’s a ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma ...

Summary: For years, scientists have suspected that the gut plays a role in Multiple Sclerosis (MS), but the “smoking gun” linking the two has been elusive. A landmark study has finally identified the ...

A Phase 1 trial of azer-cel, a CAR T-cell therapy, for progressive multiple sclerosis is now recruiting. The therapy uses donor T-cells to destroy B-cells that drive multiple sclerosis inflammation.

A map of the immune cell landscape found in the bone marrow of patients with multiple myeloma could shed light on how the immune system interacts with cancerous plasma cells. It could also help ...

Emerging immunotherapy treatments for multiple myeloma target B-cell maturation antigen (BCMA), a protein found on the surface of cancer cells. Multiple myeloma is a blood cancer that develops when ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies ...

During a live event, Jack Khouri, MD, discussed options for patients with multiple myeloma after relapse and choices to consider before CAR T-cell therapy. Jack Khouri, MD: In the NCCN guidelines, ...

Multiple myeloma (MM) is a malignant disease of plasma cells that accounts for approximately 10% of all hematological malignancies and is characterized by a clonal proliferation of malignant plasma ...